“…As soon as WHO declared the ongoing COVID-19 pandemic in March 2020, several repurposed drugs are prepared. One of them is remdesivir, that previously developed for treating hepatitis C, Ebola, and Marburg virus infections [7][8][9][10][11]. Although there are mixed results in the clinical settings, remdesivir is currently one of the standard options in COVID-19 treatments [12].…”